Northern Trust’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.49M Buy
117,610
+3,348
+3% +$106K ﹤0.01% 2511
2025
Q4
$2.49M Sell
114,262
-2,743
-2% -$57K ﹤0.01% 2868
2025
Q3
$2.51M Sell
117,005
-22,808
-16% -$511K ﹤0.01% 2907
2025
Q2
$3.59M Buy
139,813
+13,668
+11% +$400K ﹤0.01% 2662
2025
Q1
$4.62M Sell
126,145
-7,125
-5% -$245K ﹤0.01% 2458
2024
Q4
$4.09M Buy
133,270
+10,463
+9% +$348K ﹤0.01% 2623
2024
Q3
$4.62M Sell
122,807
-15,036
-11% -$580K ﹤0.01% 2524
2024
Q2
$5.46M Sell
137,843
-3,141
-2% -$102K ﹤0.01% 2348
2024
Q1
$4.74M Sell
140,984
-6,792
-5% -$228K ﹤0.01% 2492
2023
Q4
$4.92M Sell
147,776
-76
-0.1% -$2.45K ﹤0.01% 2532
2023
Q3
$4.64M Sell
147,852
-35,418
-19% -$1.11M ﹤0.01% 2486
2023
Q2
$5.81M Buy
183,270
+4,738
+3% +$153K ﹤0.01% 2427
2023
Q1
$5.9M Sell
178,532
-166
-0.1% -$5.44K ﹤0.01% 2354
2022
Q4
$5.75M Buy
178,698
+6,393
+4% +$218K ﹤0.01% 2395
2022
Q3
$6.16M Buy
172,305
+41,938
+32% +$1.74M ﹤0.01% 2330
2022
Q2
$5.35M Sell
130,367
-503
-0.4% -$24.4K ﹤0.01% 2464
2022
Q1
$7.58M Sell
130,870
-5,793
-4% -$317K ﹤0.01% 2324
2021
Q4
$8.03M Sell
136,663
-195
-0.1% -$11.8K ﹤0.01% 2393
2021
Q3
$8.31M Buy
136,858
+7,323
+6% +$429K ﹤0.01% 2412
2021
Q2
$7.77M Sell
129,535
-8,682
-6% -$435K ﹤0.01% 2548
2021
Q1
$6.52M Sell
138,217
-12,181
-8% -$501K ﹤0.01% 2576
2020
Q4
$5.65M Sell
150,398
-7,354
-5% -$242K ﹤0.01% 2612
2020
Q3
$5.16M Sell
157,752
-31,231
-17% -$1.32M ﹤0.01% 2510
2020
Q2
$8.57M Buy
188,983
+36,931
+24% +$1.89M ﹤0.01% 2195
2020
Q1
$6.94M Buy
152,052
+3,796
+3% +$172K ﹤0.01% 2116
2019
Q4
$6.41M Sell
148,256
-3,549
-2% -$145K ﹤0.01% 2442
2019
Q3
$5.5M Buy
151,805
+26,518
+21% +$1.12M ﹤0.01% 2495
2019
Q2
$5.89M Buy
125,287
+1,785
+1% +$75.4K ﹤0.01% 2474
2019
Q1
$4.34M Buy
123,502
+3,325
+3% +$131K ﹤0.01% 2638
2018
Q4
$4.49M Buy
120,177
+798
+0.7% +$31.2K ﹤0.01% 2568
2018
Q3
$4.05M Sell
119,379
-163
-0.1% -$4.77K ﹤0.01% 2816
2018
Q2
$2.98M Buy
119,542
+8,374
+8% +$233K ﹤0.01% 2985
2018
Q1
$3.32M Buy
111,168
+60
+0.1% +$2.01K ﹤0.01% 2825
2017
Q4
$3.57M Sell
111,108
-3,321
-3% -$107K ﹤0.01% 2813
2017
Q3
$3.41M Sell
114,429
-4,201
-4% -$115K ﹤0.01% 2869
2017
Q2
$2.77M Buy
118,630
+2,768
+2% +$64.3K ﹤0.01% 2967
2017
Q1
$2.53M Buy
115,862
+531
+0.5% +$12K ﹤0.01% 2969
2016
Q4
$2.6M Buy
115,331
+260
+0.2% +$6.27K ﹤0.01% 2943
2016
Q3
$2.63M Buy
115,071
+1,944
+2% +$43.4K ﹤0.01% 2929
2016
Q2
$2.42M Sell
113,127
-27,594
-20% -$869K ﹤0.01% 2921
2016
Q1
$4.83M Buy
140,721
+4,305
+3% +$114K ﹤0.01% 2425
2015
Q4
$3.75M Buy
136,416
+5,721
+4% +$156K ﹤0.01% 2644
2015
Q3
$3.91M Buy
130,695
+102,996
+372% +$3.37M ﹤0.01% 2594
2015
Q2
$1.17M Buy
27,699
+13,470
+95% +$636K ﹤0.01% 3281
2015
Q1
$711K Buy
+14,229
New +$692K ﹤0.01% 3512

Other funds holding ATEX

Northern Trust's ATEX Position: Q1 2026 in Review

Northern Trust increased its Anterix (ATEX) stake by 2.9% in Q1 2026, buying an estimated $106K and bringing the position to 117,610 shares worth $4.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2511.

Northern Trust first reported a position in ATEX in Q1 2015 and has held it in 45 quarters since. The position peaked at $8.57M in Q2 2020. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Northern Trust held 117,610 shares of Anterix worth $4.49M as of Q1 2026.
  • Northern Trust bought 3,348 Anterix shares in Q1 2026, an estimated $106K.
  • Anterix made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2511 holding.
  • Northern Trust first reported a position in Anterix in Q1 2015 and has held it in 45 quarters since.
  • Northern Trust's Anterix position peaked at $8.57M in Q2 2020.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.